ENGLEWOOD, CO — (Marketwire) — 11/04/09 — Biomedical Technology Solutions Holdings, Inc. (”BMTS” or the “Company”; www.bmtscorp.com) (OTCBB: BMTL) is pleased to announce the introduction of the Demolizer® II System into the Geisinger Health organization for the onsite treatment of biomedical waste.

The Geisinger Health System is one of the nation’s leading fully integrated health services organizations. Founded in 1915, Geisinger is a physician-led health care system, dedicated to health care, education, research and service spanning 43 counties in Pennsylvania and serving over 2.6 million people in primarily rural communities.

The Demolizer® II is a safe and simple biomedical waste treatment system ideally suited to meet the unique needs of clinics in rural areas where the cost, both financial and environmental, of traditional transport and offsite disposal can be prohibitive. Cost savings from adoption of the Demolizer® II are expected to be significant. More importantly, the Demolizer® II

ENGLEWOOD, CO–(Marketwire – 10/14/09) – Biomedical Technology Solutions Holdings, Inc. (”BMTS” or the “Company”; www.bmtscorp.com) (OTC.BB:BMTL) is pleased to announce significant developments on the commercialization of its Demolizer(R) Home unit, a safe and environmentally friendly biomedical waste disposal device designed to enable diabetics and others using syringes at home to safely destroy their sharps waste and dispose of it in the regular trash or send it to a BMTS’ recycling partner. Through treatment in the Demolizer(R) Home unit, used syringes and lancets are sterilized and grossly melted so that they cannot be reused and no longer pose a risk of infection. BMTS’ engineers have neared conclusion of the design aspects of the device and have progressed it from conception to bench testing and are implementing the patent process.

In 2006, an estimated 8 million people in the U.S. administered 3 billion injections at home annually. Most of these contaminated

ENGLEWOOD, CO — (Marketwire) — 10/07/09 — Biomedical Technology Solutions Holdings, Inc. (”BMTS” or the “Company”; www.bmtscorp.com) (OTCBB: BMTL) is pleased to announce an agreement with Med Pro Associates of Colorado to serve as a non-exclusive independent sales and marketing representative to solicit sales, obtain orders and provide sales and marketing support for the company’s Demolizer(R) II within the U.S.

Med Pro Associates, based in Idaho Springs, Colorado, is one of the nation’s largest independent representation firms specializing in the healthcare industry. They represent leading manufacturers in a sales support role through all distribution channels and market into the hospital, long term care and dental markets. The Med Pro team of highly qualified, professional field sales representatives provides national coverage and specializes in both medical equipment and disposable devices.

“Med Pro Associates is extremely excited about the addition of the BMTS line given the high profile and sensitivity

Much to the delight of Hemispherx BioPharma individual and institutional investors, a reader and follower of StocksHaven Investments has identified several key points which have been raised recently, decyphering the fact from fiction.

The following article has been submitted by an investor named, Nick DeCesare

————-

After reviewing my own research, it is time to post some serious points, some of which have already been raised by other great posters, and some have not.

First of